GID BIO IN THE NEWS
Read how recent cell-based therapy discoveries are impacting the field of medicine.
New trial site, the University of Pittsburgh Medical Center, joins GID BIO’s pivotal Phase III trial
Peter Rubin, MD, MBA, FACS, Endowed Professor and Chair of Plastic Surgery at the Center for Innovation in Restorative Medicine
AdventHealth Orlando joins as newest trial site in pivotal Phase III trial
Tariq Awan, DO, a double-certified family and sports medicine physician with a special focus in sports medicine enters as
Cell Therapy to Address Treatment Gap Between Pain Management and End-stage Surgery for Chronic Degenerative Diseases
To download the white paper click below:
Wake Forest Medical School added as newest site in pivotal Phase III trial
Neil Sparks, DO, MS, a North Carolina physician specializing in the comprehensive primary and musculoskeletal care of children, adults and
UC Davis joins as trial site in pivotal Phase III trial
Charles De Mesa, DO, MPH, a Northern California practicing specialist in anesthesiology and pain medicine, physical medicine and rehabilitation and
OrthoCarolina joins as trial site in pivotal Phase III trial
OrthoCarolina, GID BIO’s newest Phase III trial site, is led by Dr. Claude T. Moorman III as principal investigator. Dr.
San Antonio Business Journal features GID BIO and pivotal/Phase III trial principal investigator, Dr. Jaime Garza: “On the forefront of new cell therapy research, an Alamo City surgeon has a key role in moving new medical technology to market”
GID BIO completed a pivotal Phase IIb clinical trial with an FDA-compliant study design using autologous stromal cells in the
